What is required to cryopreserve hematopoietic stem cells for the field of regenerative medicine/cell therapy? - From history to the present and future of regenerative medicine -
In this seminar, Dr. Makino from Toranomon Hospital will present on the development of the cryopreservation solution CP-1 for hematopoietic stem cell storage, how it is currently used, and what is required for future regenerative medicine, from the perspective of hematopoietic stem cell transplantation. ◎ Title "Development History and Current Use of Cell Cryoprotectant CP-1 High Grade" ~ What is Required for Regenerative Medicine ~ ◎ Speaker Dr. Shigeyoshi Makino (Toranomon Hospital, Blood Transfusion Department) ◎ Date and Time September 27, 2021 (Monday) 13:00 - October 26, 2021 (Tuesday) 12:00 ◎ Target Audience Individuals involved in research, development, manufacturing, planning, and sales in the field of regenerative medicine/cell therapy * To apply for viewing this seminar, please proceed to the application form via the link below.
Inquire About This Product
basic information
【Far East Cell Preservation Solutions】 ・CP-1 High Grade ・CP-5E ・Cell Transport Preservation Solution (for refrigerated and room temperature storage) *If you would like a sample, please apply through the inquiry form. Please note that sample provision is available for new inquiries only. If you have any requests or questions, please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please see the seminar registration page. If you have any questions, please feel free to contact us.
catalog（5）
Download All Catalogs
Company information
Since its founding, Kyokuto Pharmaceutical Industrial has supported the medical field in protecting human "health" through the manufacture and sale of bacterial culture media, media and reagents for bacterial testing, and clinical testing reagents and equipment. Looking to the future, we are now adding the perspective of "preventive medicine testing" to our traditional focus on "diagnostic and therapeutic testing." Based on the technologies and know-how accumulated in clinical testing, we are also venturing into the fields of cell culture-related products that serve as raw materials for advanced medicine and pharmaceuticals, as well as food and environmental testing, embarking on new challenges.
